& Programs

Contact an Expert

White Paper | Specialty Rx

Mar 29, 2019 Decorative image - pills

Since the 1990s, the number of specialty drugs available on the market has increased exponentially. Employer-sponsored health plans have seen a rise in pharmacy expense due to the increasing availability and costs of these medications. As a result, employers are seeking ways to curb specialty Rx spend.

Download this white paper to learn:

  • Approaches to reducing spending
  • Compliance and regulatory consequences of those approaches
  • Possible solutions and considerations

Hylant Employee Benefits Specialty Rx White Paper